Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
|3||Active, not recruiting||
Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
† Study has passed its completion date and status has not been verified in more than two years.